Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62%...
Eli Lilly says Verve’s gene editor lowers cholesterol levels in early study
Eli Lilly said Monday that a high dose of its gene-editing therapy reduced cholesterol levels by 62% in participants in a clinical trial,...
Author: statnews.com
Read Original Article